Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists. (2022)
Attributed to:
The development of bispecific antibodies to promote proapoptotic immunotherapy in pancreatic cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-21-0532
PubMed Identifier: 35086954
Publication URI: http://europepmc.org/abstract/MED/35086954
Type: Journal Article/Review
Volume: 21
Parent Publication: Molecular cancer therapeutics
Issue: 4
ISSN: 1535-7163